Zoan BioMed is delighted to announce it was successful in today’s semi final of the EIT Health Catapult Programme – earning its place in the final later this year. The line up of 40 semi finalists across MedTech, BioTech and Digital Health represent some of the most exciting innovations in healthcare across Europe today. Zoan BioMed’s achievement of its place in the final is further demonstration of its continued path towards commercialisation in 2021. We look forward to the next opportunity to showcase the opportunities that our platform offers.
We would like to thank EIT for its continued support and mentorship and look forward to our future collaborations together.
The finals take place in December and you can register to attend the finals as part of EIT’s Health Summit here.
EIT Health is supported by the European Institute of Innovation and Technology, a body of the European Union, to find out more visit https://eithealth.eu/